Forte Biosciences, Inc. (FBRX)

NASDAQ: FBRX · Real-Time Price · USD

7.43

-0.33 (-4.25%)

At close: Apr 1, 2025, 4:00 PM

7.90

+0.47 (6.38%)

After-hours: Apr 1, 2025, 4:12 PM EDT

Forte Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2018
Selling, General & Admin	15.41	10.62	8.3	7.63	4.22	Upgrade
Research & Development	21.19	21.86	5.59	13.85	10	Upgrade
Operating Expenses	36.6	32.49	13.9	21.49	14.23	Upgrade
Operating Income	-36.6	-32.49	-13.9	-21.49	-14.23	Upgrade
Interest & Investment Income	1.31	1.12	0.16	-	-	Upgrade
Other Non Operating Income (Expenses)	-0.19	-0.11	-0.15	-0.22	-0.21	Upgrade
EBT Excluding Unusual Items	-35.48	-31.48	-13.88	-21.71	-14.43	Upgrade
Pretax Income	-35.48	-31.48	-13.88	-21.71	-46.49	Upgrade
Net Income	-35.48	-31.48	-13.88	-21.71	-46.49	Upgrade
Net Income to Common	-35.48	-31.48	-13.88	-21.71	-46.49	Upgrade
Shares Outstanding (Basic)	3	1	1	1	0	Upgrade
Shares Outstanding (Diluted)	3	1	1	1	0	Upgrade
Shares Change (YoY)	130.90%	81.62%	24.45%	89.81%	249.05%	Upgrade
EPS (Basic)	-12.17	-24.92	-19.96	-38.85	-157.93	Upgrade
EPS (Diluted)	-12.17	-24.92	-19.96	-38.85	-157.93	Upgrade
Free Cash Flow	-30.78	-28.79	-8.19	-16.68	-18.42	Upgrade
Free Cash Flow Per Share	-10.56	-22.80	-11.77	-29.85	-62.59	Upgrade
EBITDA	-36.56	-32.48	-13.86	-21.45	-14.17	Upgrade
D&A For EBITDA	0.04	0.01	0.04	0.04	0.05	Upgrade
EBIT	-36.6	-32.49	-13.9	-21.49	-14.23	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q